+

WO2002063013A3 - Human acid phosphatase gene - Google Patents

Human acid phosphatase gene Download PDF

Info

Publication number
WO2002063013A3
WO2002063013A3 PCT/CA2002/000105 CA0200105W WO02063013A3 WO 2002063013 A3 WO2002063013 A3 WO 2002063013A3 CA 0200105 W CA0200105 W CA 0200105W WO 02063013 A3 WO02063013 A3 WO 02063013A3
Authority
WO
WIPO (PCT)
Prior art keywords
acid phosphatase
phosphatase gene
human acid
nucleic acid
acid molecules
Prior art date
Application number
PCT/CA2002/000105
Other languages
French (fr)
Other versions
WO2002063013A2 (en
Inventor
Eleftherios P Diamandis
Maria Diamandis
George Yousef
Original Assignee
Mount Sinai Hospital Corp
Eleftherios P Diamandis
Maria Diamandis
George Yousef
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai Hospital Corp, Eleftherios P Diamandis, Maria Diamandis, George Yousef filed Critical Mount Sinai Hospital Corp
Priority to AU2002229440A priority Critical patent/AU2002229440A1/en
Publication of WO2002063013A2 publication Critical patent/WO2002063013A2/en
Publication of WO2002063013A3 publication Critical patent/WO2002063013A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to nucleic acid molecules, proteins encoded by such nucleic acid molecules; and use of the proteins and nucleic acid molecules.
PCT/CA2002/000105 2001-02-02 2002-02-01 Human acid phosphatase gene WO2002063013A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002229440A AU2002229440A1 (en) 2001-02-02 2002-02-01 Human acid phosphatase gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26625301P 2001-02-02 2001-02-02
US60/266,253 2001-02-02

Publications (2)

Publication Number Publication Date
WO2002063013A2 WO2002063013A2 (en) 2002-08-15
WO2002063013A3 true WO2002063013A3 (en) 2003-04-10

Family

ID=23013809

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2002/000105 WO2002063013A2 (en) 2001-02-02 2002-02-01 Human acid phosphatase gene

Country Status (2)

Country Link
AU (1) AU2002229440A1 (en)
WO (1) WO2002063013A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20041453A0 (en) * 2004-11-11 2004-11-11 Pirkko Vihko Knockout Animals
FI20075466A0 (en) * 2007-06-19 2007-06-19 Chempath Oy Transmembrane acid phosphatase in the prostate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075067A2 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001079454A1 (en) * 2000-04-13 2001-10-25 Smithkline Beecham Corporation Novel compounds
WO2002010363A2 (en) * 2000-07-28 2002-02-07 Incyte Genomics, Inc. Protein phosphatases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075067A2 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001079454A1 (en) * 2000-04-13 2001-10-25 Smithkline Beecham Corporation Novel compounds
WO2002010363A2 (en) * 2000-07-28 2002-02-07 Incyte Genomics, Inc. Protein phosphatases

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EBI; 15 March 1998 (1998-03-15), NCI-CGAP: "ak37c02.s1 Soares_testis_NHT Homo sapiens cDNA clone IMAGE:1408130 3' similar to SW:PPAP_HUMAN P15309 PROSTATIC ACID PHOSPHATASE PRECURSOR; mRNA sequence.", XP002215450, Database accession no. AA861388 *
DATABASE EMBL [online] EBI; 17 September 1999 (1999-09-17), DOE JOINT GENOME INSTITUTE STANDFORD HUMAN GENOME CENTER: "Homo sapiens chromosome 19 clone CTD-2568A17, complete sequence.", XP002215449, Database accession no. AC010325 *
DATABASE GENBANK [online] NIH; 21 June 2000 (2000-06-21), DOE JOINT GENOME INSTITUTE: "Homo sapiens chromosome 19 clone CTD-2568A17, working draft sequence, 23 unordered pieces.", XP002215462, Database accession no. AC010325 *
DATABASE GENSEQ [online] 11 October 2001 (2001-10-11), DRMANAC ET AL.: "Novel human diagnostic protein #23339", XP002215463, retrieved from ABG23348 *
GEIER C ET AL: "STRUCTURE OF THE HUMAN LYSOSOMAL ACID PHOSPHATASE GENE", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 183, 1989, pages 611 - 616, XP002906605, ISSN: 0014-2956 *
SHARIEF F S ET AL: "HUMAN PROSTATIC ACID PHOSPHATASE: CDNA CLONING, GENE MAPPING AND PROTEIN SEQUENCE HOMOLOGY WITH LYSOSOMAL ACID PHOSPHATASE", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 160, no. 1, 14 April 1989 (1989-04-14), pages 79 - 86, XP002031414, ISSN: 0006-291X *
YOUSEF GEORGE M ET AL: "Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis.", GENOMICS, vol. 74, no. 3, 15 June 2001 (2001-06-15), pages 385 - 395, XP002215448, ISSN: 0888-7543 *

Also Published As

Publication number Publication date
WO2002063013A2 (en) 2002-08-15
AU2002229440A1 (en) 2002-08-19

Similar Documents

Publication Publication Date Title
WO2002014485A3 (en) Kallikrein gene
WO2000053776A3 (en) Human kallikrein-like genes
AU2002324458A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
WO2002063013A3 (en) Human acid phosphatase gene
AU2002258630A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002258617A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002356494A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002250346A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002254438A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002303137A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002257075A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002324475A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002327214A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002243460A1 (en) Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
AU2002307004A1 (en) Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
AU2002243459A1 (en) Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof
AU2002322317A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002257117A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
EP1383876A4 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002240295A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002257016A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002228599A1 (en) Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof
WO2002099072A8 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins and uses thereof
AU2002326351A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
WO2003006605A9 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载